Smith et al., 3 had provided pain relieffor an ischaemic foot with a continuous sciatic nerve block using a catheter inserted from the posterior approach. Economacos 4 reported forty-four patients in whom a sciatic nerve catheter had been placed by either anterior, lateral or posterior approach. Because of our patient's position and traction an anterior approach was necessary to insert an indwelling catheter. We found that sciatic nerve block via this catheter provided excellent analgesia.
Repeated nerve blocks are uncommonly performed in this hospital and in this case there were administrative difficulties that resulted in early cessation of treatment. It is hoped that an acute pain management unit, able to deal with such patients, will be established at this hospital.
Repeated sciatic nerve blockade using 0.25% or 0.5% bupivacaine with adrenaline provided excellent relief of pain that was previously poorly controlled with opioids as ordered by the surgical team. The patient had however received opioids for nearly four weeks and a progressive reduction in dose would have been appropriate in order to avoid the clinical features of sudden withdrawal.
She had been a heavy smoker until four months prior to surgery, when she developed vague right-sided chest pain and felt tired and forgetful. Chest X-ray and CT scan of the chest revealed a mediastinal mass.
Her past history included hypertension treated with metoprolol and diet-controlled diabetes.
She had had three uneventful general anaesthetics for caesarean section, the last being thirty years ago. Routine preoperative assessment revealed no abnormality.
Premedication was pethidine 75 mg and phernergan 25 mg IMI one hour prior to Thirty minutes into the procedure her BP rose from 100 mmHg systolic to 160 mmHg. Isoflurane 1 % was added for ten minutes. A further 1.0 mg of vecuronium was given to avoid the serious risk of coughing as the surgery was longer and more difficult than anticipated.
Eight minutes after induction and thirty minutes after the last increment of vecuronium, atropine 1.8 mg and neostigmine 3.75 mg resulted in no clinical reversal of neuromuscular blockade. A nerve stimulator revealed no response to train-of-four stimulation. The patient was ventilated for a further thirty minutes and a subsequent dose of atropine 1.2 mg and neostigmine 2.5 mg was given. This resulted in one palpable twitch on train-of-four stimulation and a small unsustained response to 50 Hz tetanic stimulation.
She then required ventilation for a further four hours. At this time she had a FVC of 1.8 litres and normal arterial blood gases when breathing spontaneously and was extubated. Her subsequent postoperative course was uneventful.
In view of the prolonged neuromuscular blockade in the presence of a mediastinal mass a provisional diagnosis of occult myasthenia gravis was made. This was supported by further questioning which revealed that for the last three months she had been unable to rise out of a chair unassisted and had to be supported when walking, especially at the end of the day. There was neither ocular nor pharyngeal involvement. An EMG of the abductor digiti minimi, abductor pollicis brevis and tibialis anterior showed a 20 to 25% decrement to 3, 5 and 20 Hz stimulation. No increment was observed at higher frequencies. This is consistent with a diagnosis of myasthenia gravis. The histopathology of the mediastinal lesion was reported as 'tumour of lymphoid origin, probably a thymoma'.
The patient was referred to a physician for subsequent management. 
DISCUSSION
During diagnostic mediastinoscopy the anaesthetist must be aware of the possibility of previously undiagnosed myasthenia gravis or myasthenic syndrome. Thymic lesions represent one of the most common types of primary mediastinal tumours for which mediastinoscopy is performed. 4 The incidence of myasthenia gravis in patients with thymoma may be as high as 50%. 4 Mediastinoscopy is also frequently performed for staging of carcinoma of the lung,S which may be associated with myasthenic syndrome with resulting extreme sensitivity to depolarising and nondepolarising muscle relaxants. 6 Therefore in all patients undergoing mediastinoscopy a careful history should be obtained. Due to the risk of bleeding, a large bore intravenous cannula should be used and the right radial artery pulse continuously monitored. Arterial blood pressure, oxygen saturation, and neuromuscular function should be closely monitored. A muscle relaxant is necessary during the procedure to prevent coughing and straining with resultant perforation of great vessels or venous engorgement which would increase the risk of bleeding. 3 A tracuri urn appears to be the nondepolarising muscle relaxant of choice in myasthenia gravis (and myasthenic syndrome) as it results in less prolonged neuromuscular blockade due to its short elimination half-life of twenty-two minutes and lack of cumulative side-effects.? This relatively rapid and complete elimination is important in circumstances in which there is greatly increased sensitivity to relaxants. 8 The elimination half-life of vecuronium is 71 minutes? and although comparison between different studies is difficult, Buzello's9 myasthenia gravis patients who had vecuronium had more prolonged neuromuscular blockade and required longer postoperative ventilatory support than Bell's patients who had atracurium. 8 In view of this, vecuronium appears not be the relaxant of choice for mediastinoscopy and atracurium would seem to be the preferred drug. Continuous monitoring of neuromuscular transmission would be a helpful adjunct to management.
